Trials / Completed
CompletedNCT06200636
Edge AI-deployed DIGItal Twins for PREDICTing Disease Progression and Need for Early Intervention in Infectious and Cardiovascular Diseases Beyond COVID-19 - Investigation of Biomarkers in Dermal Interstitial Fluid
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 20 (actual)
- Sponsor
- Charite University, Berlin, Germany · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The study will investigate, if inflammatory and cardio-circulatory biochemical biomarkers are detectable in dermal interstitial fluid (dISF) of heart failure patients, and if there are detectable kinetics of these biomarkers during a cardiopulmonary exercise test. For dISF extraction the PELSA System - an investigational device - will be used.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Use of the PELSA System for dISF extraction | Dermal interstitial fluid will be extracted using the investigational device, for further analysis. |
Timeline
- Start date
- 2024-04-16
- Primary completion
- 2024-12-06
- Completion
- 2024-12-06
- First posted
- 2024-01-11
- Last updated
- 2026-03-12
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT06200636. Inclusion in this directory is not an endorsement.